Status:
COMPLETED
Analysis of T-Cell Immune Reconstitution Following Allogeneic Hematopoietic BMT for Severe SCD
Lead Sponsor:
Emory University
Conditions:
Sickle Cell Disease
Eligibility:
All Genders
6-21 years
Brief Summary
In this study, patient blood samples from NMA transplants will be provided by Pittsburgh, and samples from myeloablative transplants will be provided by Atlanta (comparative controls). Samples would b...
Detailed Description
Sickle cell disease (SCD) is a serious inherited disorder of red blood cells that shortens life and causes life-long problems. One of the most common genetic diseases in America, SCD affects 1 of ever...
Eligibility Criteria
Inclusion
- Undergoing allogeneic bone marrow transplantation for sickle cell disease.
Exclusion
- \-
Key Trial Info
Start Date :
September 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT00228631
Start Date
September 1 2005
End Date
July 1 2012
Last Update
May 26 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Healthcare of Atlanta
Atlanta, Georgia, United States, 30322